Seasonal Affective Disorder (SAD)

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

GSK
GSKLONDON, United Kingdom
1 program
1
Investigational Seasonal Affective DisorderPhase 31 trial
Active Trials
NCT00046449CompletedEst. Jun 2003

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
GSKInvestigational Seasonal Affective Disorder

Clinical Trials (1)

NCT00046449GSKInvestigational Seasonal Affective Disorder

Prevention of Seasonal Affective Disorder

Start: Sep 2002Est. completion: Jun 2003
Phase 3Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
1 companies competing in this space